Alaunos Therapeutics Inc
NASDAQ:TCRT
Intrinsic Value
The intrinsic value of one TCRT stock under the Base Case scenario is 0.08 USD. Compared to the current market price of 2.84 USD, Alaunos Therapeutics Inc is Overvalued by 97%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Alaunos Therapeutics Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Alaunos Therapeutics Inc
Balance Sheet Decomposition
Alaunos Therapeutics Inc
Current Assets | 2.8m |
Cash & Short-Term Investments | 1.1m |
Receivables | 5k |
Other Current Assets | 1.7m |
Free Cash Flow Analysis
Alaunos Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Alaunos Therapeutics Inc
Revenue
|
10k
USD
|
Operating Expenses
|
-4.8m
USD
|
Operating Income
|
-4.8m
USD
|
Other Expenses
|
133k
USD
|
Net Income
|
-4.7m
USD
|
TCRT Profitability Score
Profitability Due Diligence
Alaunos Therapeutics Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.
Score
Alaunos Therapeutics Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.
TCRT Solvency Score
Solvency Due Diligence
Alaunos Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Alaunos Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TCRT Price Targets Summary
Alaunos Therapeutics Inc
Dividends
Current shareholder yield for TCRT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TCRT stock under the Base Case scenario is 0.08 USD.
Compared to the current market price of 2.84 USD, Alaunos Therapeutics Inc is Overvalued by 97%.